Hong Kong · Delayed Price · Currency is HKD Sino Biopharmaceutical Statistics
Total Valuation
HKG:1177 has a market cap or net worth of HKD 89.56 billion. The enterprise value is 94.59 billion.
| Market Cap | 89.56B |
| Enterprise Value | 94.59B |
Important Dates
The next estimated earnings date is Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | Jun 24, 2026 |
Share Statistics
HKG:1177 has 17.81 billion shares outstanding. The number of shares has decreased by -1.30% in one year.
| Current Share Class | 17.81B |
| Shares Outstanding | 17.81B |
| Shares Change (YoY) | -1.30% |
| Shares Change (QoQ) | +0.34% |
| Owned by Insiders (%) | 51.06% |
| Owned by Institutions (%) | 18.97% |
| Float | 8.71B |
Valuation Ratios
The trailing PE ratio is 34.82 and the forward PE ratio is 17.95. HKG:1177's PEG ratio is 1.14.
| PE Ratio | 34.82 |
| Forward PE | 17.95 |
| PS Ratio | 2.53 |
| PB Ratio | 1.91 |
| P/TBV Ratio | 2.98 |
| P/FCF Ratio | 9.99 |
| P/OCF Ratio | 8.66 |
| PEG Ratio | 1.14 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.84, with an EV/FCF ratio of 10.56.
| EV / Earnings | 36.28 |
| EV / Sales | 2.67 |
| EV / EBITDA | 11.84 |
| EV / EBIT | 13.84 |
| EV / FCF | 10.56 |
Financial Position
The company has a current ratio of 1.37, with a Debt / Equity ratio of 0.38.
| Current Ratio | 1.37 |
| Quick Ratio | 1.23 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | 2.19 |
| Debt / FCF | 2.00 |
| Interest Coverage | 22.60 |
Financial Efficiency
Return on equity (ROE) is 12.53% and return on invested capital (ROIC) is 13.68%.
| Return on Equity (ROE) | 12.53% |
| Return on Assets (ROA) | 5.56% |
| Return on Invested Capital (ROIC) | 13.68% |
| Return on Capital Employed (ROCE) | 12.38% |
| Weighted Average Cost of Capital (WACC) | 6.60% |
| Revenue Per Employee | 1.65M |
| Profits Per Employee | 121,656 |
| Employee Count | 21,435 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 2.47 |
Taxes
In the past 12 months, HKG:1177 has paid 1.81 billion in taxes.
| Income Tax | 1.81B |
| Effective Tax Rate | 23.46% |
Stock Price Statistics
The stock price has decreased by -33.11% in the last 52 weeks. The beta is 0.62, so HKG:1177's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | -33.11% |
| 50-Day Moving Average | 4.86 |
| 200-Day Moving Average | 6.08 |
| Relative Strength Index (RSI) | 50.26 |
| Average Volume (20 Days) | 115,204,259 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1177 had revenue of HKD 35.43 billion and earned 2.61 billion in profits. Earnings per share was 0.14.
| Revenue | 35.43B |
| Gross Profit | 29.07B |
| Operating Income | 7.00B |
| Pretax Income | 7.73B |
| Net Income | 2.61B |
| EBITDA | 8.07B |
| EBIT | 7.00B |
| Earnings Per Share (EPS) | 0.14 |
Balance Sheet
The company has 25.55 billion in cash and 17.88 billion in debt, with a net cash position of 7.67 billion or 0.43 per share.
| Cash & Cash Equivalents | 25.55B |
| Total Debt | 17.88B |
| Net Cash | 7.67B |
| Net Cash Per Share | 0.43 |
| Equity (Book Value) | 46.83B |
| Book Value Per Share | 1.91 |
| Working Capital | 10.31B |
Cash Flow
In the last 12 months, operating cash flow was 10.34 billion and capital expenditures -1.38 billion, giving a free cash flow of 8.96 billion.
| Operating Cash Flow | 10.34B |
| Capital Expenditures | -1.38B |
| Depreciation & Amortization | 1.12B |
| Net Borrowing | 7.37B |
| Free Cash Flow | 8.96B |
| FCF Per Share | 0.50 |
Margins
Gross margin is 82.07%, with operating and profit margins of 19.76% and 7.36%.
| Gross Margin | 82.07% |
| Operating Margin | 19.76% |
| Pretax Margin | 21.81% |
| Profit Margin | 7.36% |
| EBITDA Margin | 22.79% |
| EBIT Margin | 19.76% |
| FCF Margin | 24.23% |
Dividends & Yields
This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 1.99%.
| Dividend Per Share | 0.10 |
| Dividend Yield | 1.99% |
| Dividend Growth (YoY) | -44.44% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 64.12% |
| Buyback Yield | 1.30% |
| Shareholder Yield | 3.28% |
| Earnings Yield | 2.91% |
| FCF Yield | 10.01% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for HKG:1177 is 8.13, which is 61.63% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 8.13 |
| Price Target Difference | 61.63% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 22 |
| Revenue Growth Forecast (3Y) | 10.67% |
| EPS Growth Forecast (3Y) | 3.79% |
Stock Splits
The last stock split was on July 20, 2020. It was a forward split with a ratio of 1.5.
| Last Split Date | Jul 20, 2020 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
HKG:1177 has an Altman Z-Score of 2.92 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.92 |
| Piotroski F-Score | 7 |